|
|
Post by kbrion77 on Aug 7, 2017 15:48:38 GMT -5
Nobody surprised.....Obvious this is going BK. TASE is another clue of it.... Have a nice day to all......Tomorrow u can buy below $1..... And with diluition coming you can buy at 0.20 soon..... The new DRYS is here. You shorts should really be ashamed! You just couldn't wait to bash the financial and claim that This is going BK. BS you are just trying to scare as many longs out of there shares as possible. Most of you people posting on this topic are just trying to scare longs into selling. There is no new news here. So begone with ya. And that is exactly the problem. The company will not survive unless there is an influx of news from now until October. Like I said it's going to get slammed in after hours it's already down 6% but hey what do I know. |
|
|
|
Post by madog365 on Aug 7, 2017 15:52:15 GMT -5
Literally only the shorts posting on this thread... too funny guys.
|
|
|
|
Post by kc on Aug 7, 2017 15:53:50 GMT -5
It is what it is. Until there are some sales there will be no progress and perhaps bankruptcy. I'm a big boy and understand the risk. Not fun but there is not much we can do until the product sells or the company sell to another Pharma.
|
|
|
|
Post by oldfishtowner on Aug 7, 2017 15:54:08 GMT -5
The numbers speak for themselves. They just cannot continue to go on unless something big (nothing short of a miracle) happens. They had better have an ace up their sleeve because these financial numbers truly, truly suck. The cost of inventory expired due to expiration date exceeds the revenue. Wow!  "The cost of inventory expired due to expiration date exceeds the revenue. " Although this is not good, it was to be expected. In reality it doesn't matter because it is a paper write-off. Its effect on cash was some time ago and it is cash that matters now. Cash and scripts have to be the real focus. Ignore the other noise, both good and bad. |
|
|
|
Post by dreamboatcruise on Aug 7, 2017 15:59:42 GMT -5
They had better have an ace up their sleeve because these financial numbers truly, truly suck. The cost of inventory expired due to expiration date exceeds the revenue. Wow! "The cost of inventory expired due to expiration date exceeds the revenue. " Although this is not good, it was to be expected. In reality it doesn't matter because it is a paper write-off. Its effect on cash was some time ago and it is cash that matters now. Cash and scripts have to be the real focus. Ignore the other noise, both good and bad. Though I think this can put to rest that we aren't shipping $200M worth of Afrezza to UAE, right? Is the unicorn crowd willing to concede that point? Also gives some indication that there is nothing expected that is going to make the sales soar in short term. [nearly had Freudian slip of writing "sales sore"] |
|
|
|
Post by derek2 on Aug 7, 2017 16:06:06 GMT -5
"The cost of inventory expired due to expiration date exceeds the revenue. " Although this is not good, it was to be expected. In reality it doesn't matter because it is a paper write-off. Its effect on cash was some time ago and it is cash that matters now. Cash and scripts have to be the real focus. Ignore the other noise, both good and bad. Though I think this can put to rest that we aren't shipping $200M worth of Afrezza to UAE, right? Is the unicorn crowd willing to concede that point? Also gives some indication that there is nothing expected that is going to make the sales soar in short term. [nearly had Freudian slip of writing "sales sore"] Well, given that they have not sought approval in any foreign jurisdiction... |
|
|
|
Post by exwannabe on Aug 7, 2017 16:09:03 GMT -5
They had better have an ace up their sleeve because these financial numbers truly, truly suck. The cost of inventory expired due to expiration date exceeds the revenue. Wow! "The cost of inventory expired due to expiration date exceeds the revenue. " Although this is not good, it was to be expected. In reality it doesn't matter because it is a paper write-off. Its effect on cash was some time ago and it is cash that matters now. Cash and scripts have to be the real focus. Ignore the other noise, both good and bad. The write off is old news, no argument. But backing that out, gross margin still went negative. That was not clear from Q1 as those sales numbers included bulk insulin. And SGA went up another $3M to $18.5M. That is real cash. |
|
|
|
Post by thall on Aug 7, 2017 16:42:27 GMT -5
The trepostinil IND announcement makes it clear MNKD management has zero expectation the company will be out of money this year. I can't wait to hear what MNKD management knows and we don't! Wasn't there an announcement about an FDA meeting about an IND for epi-TS at some point? What happened to that? |
|
|
|
Post by brentie on Aug 7, 2017 17:11:39 GMT -5
 again. |
|
|
|
Post by peppy on Aug 7, 2017 17:13:23 GMT -5
submitted with label change 
|
|
|
|
Post by esstan2001 on Aug 7, 2017 17:16:00 GMT -5
call started weak, but finished strong. Just everything is so damn slow, and the time waits for no one...
|
|
|
|
Post by peppy on Aug 7, 2017 17:16:31 GMT -5
The new boxes. out with the old (inventory), in with the new. no wonder they configurations were no place to be found.
|
|
|
|
Post by traderdennis on Aug 7, 2017 17:18:54 GMT -5
call started weak, but finished strong. Just everything is so damn slow, and the time waits for no one... Esstan, What is the solution regarding their cash situation discussed in detail on the call? |
|
|
|
Post by peppy on Aug 7, 2017 17:21:36 GMT -5
our vasodilator candidate. (The FDA was positive) I will never stop laughing. It's a Man's world.
|
|
|
|
Post by dreamboatcruise on Aug 7, 2017 17:23:26 GMT -5
call started weak, but finished strong. Just everything is so damn slow, and the time waits for no one... Esstan, What is the solution regarding their cash situation discussed in detail on the call? Sale of Danbury plant and lease back. Does anyone know enough about these type of deals to know how likely they could successfully monetize that asset and what might be expected based on approx value of said property? It seems possible that weak finances might complicate doing this since a landlord wouldn't want a tennant incapable of paying the lease. So the likelihood of this probably a lot lower if asset clearly wouldn't bring enough to get them clear out of the woods. |
|
/production/original_573352236.gif)
